Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Improvement of Renal Function by Conversion of Tacrolimus to Everolimus 3 Months After Kidney Transplantation
2010-019398-14Phase 4Active
- Sponsor
- Erasmus MC
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of everolimus in kidney allograft rejection (2 arms), sponsored by Erasmus MC. Primary endpoints: Primary renal function comparison at 12 months and Within-patient change in MDRD clearance from month 3 to 12. Started Jun 2010; status: active.
02
Drugs
everolimus
03
Conditions
kidney allograft rejection
Beyond the preview
Go deeper on 2010-019398-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019398-14.